1 year return (CAGR)
-67.52%
Akebia Ther Exchange (NASDAQ, USD)
AKBA
0.90
+0.00 (+0.50%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-8.69%
5 year return (CAGR)
-21.24%
10 year return (CAGR)
-19.31%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
263.72M
Price/Sales
1.20
Ent value
432.81M
Price/Book
10.54
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-62.40%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.97 |
| Daily high | 0.98 |
| Daily low | 0.95 |
| Daily Volume | 6.14M |
| All-time high | 29.17 |
| 1y analyst estimate | 3.80 |
| Beta | 0.23 |
| EPS (TTM) | -0.11 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AKBA | S&P500 | |
| Current price drop from All-time high | -96.93% | -1.96% |
| Highest price drop | -99.14% | -56.47% |
| Date of highest drop | 29 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -77.63% | -10.68% |
| Avg time to new high | 448 days | 12 days |
| Max time to new high | 3075 days | 1805 days |
News
